+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis



Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis



Patient 11(3): 329-340



Clinical trials and observational studies lacking measures of health-related quality of life (QoL) are often inapplicable when conducting cost-effectiveness analyses using quality-adjusted life-years (QALYs). The only solution is to map QoL ex post from additionally collected clinical outcomes and generic QoL instruments. Nonetheless, mapping studies are absent in psoriatic arthritis (PsA). In this 2-year, prospective, multicentre, non-interventional study of PsA patients, EQ-5D and key clinical parameters such as Disease Activity in PsA (DAPsA), clinical DAPsA (cDAPsA; DAPsA without C-reactive protein [CRP]), and Health Assessment Questionnaire disability index (HAQ) were collected. We employed a linear mixed-effect regression model (ME) of the longitudinal dataset to explore the best predictors of QoL. A total of 228 patients were followed over 873 appointments/observations. DAPsA, cDAPsA and HAQ were stable and highly significant predictors of EQ-5D utilities in both cross-sectional and longitudinal analyses. The best prediction was provided using a linear ME with HAQ and cDAPsA or DAPsA. A HAQ increase of 1 point represented a decrease in EQ-5D by -0.204 or -0.203 (p < 0.0001); a one-point increase in cDAPsA or DAPsA dropped EQ-5D equally by -0.005 (p < 0.0001). The ME revealed steeper and more accurate association compared with cross-sectional regressions or non-linear models/transformations. This is the first mapping study conducted in PsA and we hope that our study will encourage further mapping studies in PsA. The results showed that in cases where CRP is absent, cDAPsA provides similar results to DAPsA in predicting QoL.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059944249

Download citation: RISBibTeXText

PMID: 29164493

DOI: 10.1007/s40271-017-0285-1


Related references

DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort. Clinical and Experimental Rheumatology 35(6): 936-942, 2017

The Assessment of Disease Activity in Psoriatic Arthritis: Mda, Vlda, Dapsa, or Something Else?. The Journal of Rheumatology 46(7): 663-664, 2019

Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis. Annals of the Rheumatic Diseases 78(3): 350-354, 2019

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Annals of the Rheumatic Diseases 69(8): 1441-1447, 2010

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Annals of the Rheumatic Diseases 75(5): 811-818, 2016

SAT0575Disease Activity in Psoriatic Arthritis (PSA): Defining Remission and Treatment Success Using the Dapsa-Score. Annals of the Rheumatic Diseases 74(Suppl 2): 869.1-869, 2015

AB0930DAREA/DAPSA (disease activity score for reactive arthritis/disease activity index for psoriatic arthritis) and related variables in patients with psoriatic arthritis (PSA):. Annals of the Rheumatic Diseases 71(Suppl 3): 691.18-691, 2013

Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?. Annals of the Rheumatic Diseases 77(12): 1736-1741, 2018

SAT0398Application of Disease Activity Index for Psoriatic Arthritis (DAPSA) in A Cohort of Patients Followed in The Institute of Rheumatology Prague. Annals of the Rheumatic Diseases 75(Suppl 2): 813.2-813, 2016

Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression. Annals of the Rheumatic Diseases 76(2): 418-421, 2017

FRI0568Disease Activity States of The Dapsa, A Psoriatic Arthritis Specific Instrument, Are Valid against The Constructs of Functional Status and Structural Progression. Annals of the Rheumatic Diseases 75(Suppl 2): 646.3-647, 2016

Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. Clinical and Experimental Rheumatology 33(5 Suppl 93): S48, 2015

Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis. Journal of Rheumatology 46(7): 710-715, 2019

To DAPSA or not to DAPSA? That is not the question. Annals of the Rheumatic Diseases 78(7): E61, 2019

DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs. Rmd Open 4(2): E000765, 2018